about
Selective microRNA-Offset RNA expression in human embryonic stem cellsIntestinal Commitment and Maturation of Human Pluripotent Stem Cells Is Independent of Exogenous FGF4 and R-spondin1Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and DifferentiationHuman pluripotent stem cell based islet models for diabetes research.An Activating STAT3 Mutation Causes Neonatal Diabetes through Premature Induction of Pancreatic Differentiation.A Strong Contractile Actin Fence and Large Adhesions Direct Human Pluripotent Colony Morphology and Adhesion.p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming.A complex genomic locus drives mtDNA replicase POLG expression to its disease-related nervous system regions.Generation of a SOX2 reporter human induced pluripotent stem cell line using CRISPR/SaCas9.Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9.Human pluripotent reprogramming with CRISPR activators.Human pluripotent stem cells for the modelling of pancreatic beta-cell pathologyTranscription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like CellsRedox regulation of GRPEL2 nucleotide exchange factor for mitochondrial HSP70 chaperoneInsulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetesPancreatic β-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetesPharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapyPublisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
P50
Q35231184-DB4F0D3E-F166-43EA-9086-E2DE5DB0C823Q35729991-949FE1BB-A6BA-4663-8004-A54CE10BFFB3Q36201570-9365C8DF-5008-41B0-82E4-5EB9497BA23AQ38676920-28C530F5-BA27-42B8-BF96-4232D3604CB2Q38707990-13838E1A-3D72-4C7F-B0B5-FFF0490A13C5Q41019165-EECCFD4C-C6EA-46EA-9586-9650896C24DFQ42261454-47838047-FC75-4B7D-A682-75F502F6CE1EQ47434262-688D3ABE-03AC-4D09-B133-EDA334CC1A74Q49788889-FEFD73E1-5A57-42E8-A9A6-84AA0CBB9F77Q50026142-E3CCB5DC-6D67-49DE-8636-19DA7F4B6849Q55509998-70EF412E-D33D-4EDB-A451-BE078B3465F8Q57064373-BA5ECC1F-DBB2-4E26-8F6C-4A9E4210D484Q57461996-D040BEEA-D0CC-4A0D-AACD-83D83BF85261Q58452251-11A51C18-6C10-497D-AD01-4829AA4FD97FQ58563634-D6846E2E-64DA-4B22-87CB-F29CD60007FAQ58702444-49F05785-81BB-44AA-BD1E-ECE77FA1959CQ61798926-D10A40F0-0B7A-484D-B9CD-9E8BF17E5A81Q64263825-4396BBF2-EB25-4AE1-9744-9CE733B237C1
P50
description
researcher ORCID ID = 0000-0002-4784-5452
@en
wetenschapper
@nl
name
Diego Balboa
@ast
Diego Balboa
@en
Diego Balboa
@es
Diego Balboa
@nl
type
label
Diego Balboa
@ast
Diego Balboa
@en
Diego Balboa
@es
Diego Balboa
@nl
prefLabel
Diego Balboa
@ast
Diego Balboa
@en
Diego Balboa
@es
Diego Balboa
@nl
P106
P21
P31
P496
0000-0002-4784-5452